- Home
- MBCN vs LYEL Comparison
MBCN vs LYEL Comparison
Compare MBCN & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBCN
- LYEL
- Stock Information
- Founded
- MBCN 1901
- LYEL 2018
- Country
- MBCN United States
- LYEL United States
- Employees
- MBCN N/A
- LYEL N/A
- Industry
- MBCN Major Banks
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- MBCN Finance
- LYEL Health Care
- Exchange
- MBCN Nasdaq
- LYEL Nasdaq
- Market Cap
- MBCN 236.1M
- LYEL 207.7M
- IPO Year
- MBCN N/A
- LYEL 2021
- Fundamental
- Price
- MBCN $31.31
- LYEL $12.31
- Analyst Decision
- MBCN Hold
- LYEL Sell
- Analyst Count
- MBCN 1
- LYEL 2
- Target Price
- MBCN $33.00
- LYEL $15.00
- AVG Volume (30 Days)
- MBCN 6.9K
- LYEL 25.4K
- Earning Date
- MBCN 10-16-2025
- LYEL 11-06-2025
- Dividend Yield
- MBCN 2.73%
- LYEL N/A
- EPS Growth
- MBCN 16.03
- LYEL N/A
- EPS
- MBCN 2.25
- LYEL N/A
- Revenue
- MBCN $70,503,000.00
- LYEL $60,000.00
- Revenue This Year
- MBCN $18.85
- LYEL N/A
- Revenue Next Year
- MBCN $6.69
- LYEL N/A
- P/E Ratio
- MBCN $13.65
- LYEL N/A
- Revenue Growth
- MBCN 5.64
- LYEL 11.11
- 52 Week Low
- MBCN $22.74
- LYEL $7.65
- 52 Week High
- MBCN $34.00
- LYEL $32.00
- Technical
- Relative Strength Index (RSI)
- MBCN 56.82
- LYEL 54.52
- Support Level
- MBCN $29.86
- LYEL $12.59
- Resistance Level
- MBCN $31.50
- LYEL $13.62
- Average True Range (ATR)
- MBCN 0.78
- LYEL 0.72
- MACD
- MBCN 0.06
- LYEL 0.06
- Stochastic Oscillator
- MBCN 92.88
- LYEL 54.24
About MBCN Middlefield Banc Corp.
Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.